As part of our monthly news service we would like to make you aware of the CML publications of the month. From the many papers published every month Professor Timothy Hughes has selected topical, interesting papers for your perusal that also include interesting articles from the emerging economic regions and publications on COVID-19 and CML.

Read Professor Hughes' CML publications of the month: April 2023

Clinical papers

• The outcome of post-transplant asciminib in patients with CML
  Fernando F et al. Bone Marrow Transplant, April 2023 (epub ahead of print)
• Health-related quality of life of patients with resistant/intolerant chronic phase chronic myeloid leukemia treated with asciminib or bosutinib in the phase 3 ASCEMBL trial
  Réa D et al. Leukemia, April 2023 (epub ahead of print) – open access publication
  
• Management of chronic myeloid leukemia in 2023 – Common ground and common sense - Review
  Senapati J et al. Blood Cancer J, April 2023 – open access publication
  
• Efficacy and safety of nilotinib in chronic myeloid leukemia patients who failed to achieve a treatment-free remission period after imatinib discontinuation: Results of the French Nilo post-STIM study
  Dulucq S et al. Br J Haematol, April 2023 (epub ahead of print) – open access publication
  
• Clonal hematopoiesis onset in chronic myeloid leukemia patients developing an adverse cardiovascular event
  Tarantini F et al. Leuk Res, April 2023
• Managing women of childbearing age with chronic myeloid leukemia: Safety and treatment considerations
  Expert Rev Hematol, April 2023 (epub ahead of print)
• Real-world imatinib mesylate treatment in patients with chronic myeloid leukemia: The importance of molecular monitoring and the early molecular response
  Ferreira APS et al. Ann Hematol, April 2023 (epub ahead of print) – open access publication
  
• An analysis of dasatinib treatment patterns in patients with chronic myeloid leukemia after experiencing pleural effusion during dasatinib therapy
  McBride A et al. Acta Haematol, April 2023 (epub ahead of print)
• Efficacy and safety of nilotinib as frontline therapy in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trials
  Luciano L et al. Ann Hematol, April 2023 (epub ahead of print) – open access publication
  
• Applications of machine learning in chronic myeloid leukemia - Review
  Elhadary M et al. Diagnostics(Basel), April 2023 – open access publication

Scientific papers

• New patterns of genetic instability in chronic myelogenous leukemia: interesting, but not ready for clinical use
  Schiffer CA. Haematologica, April 2023 (epub ahead of print) – open access publion
  
• The structure of the hematopoietic system can explain chronic myeloid leukemia progression
  Pérez-Jiménez M et al. Sci Rep, April 2023 – open access publication
• Characterization of bone marrow niche in chronic myeloid leukemia patients identifies CXCL14 as a new therapeutic option
  Polinska M et al. Blood, April 2023 (epub ahead of print)
• IL-18 and VEGF-A trigger type 2 innate lymphoid cell accumulation and pro-tumoral function in chronic myeloid leukemia
  Fiordi B et al. Haematologica, April 2023 (epub ahead of print) – open access publication
• Molecular subtypes predict therapeutic responses and identifying and validating diagnostic signatures based on machine learning in chronic myeloid leukemia
  Zhong FM et al. Cancer Cell Int, April 2023 – open access publication

 LMIC papers

• Kinetic of liver enzymes and serum electrolytes in HCV, HBV, and HIV negative chronic phase chronic myeloid leukemia patients treated with imatinib or nilotinib
  Abdel Hammed MR et al. Egypt J Immunol, April 2023
• Efficacy of flumatinib in CML patients with F359V/C mutation
  Gao H et al. Indian J Hematol Transfus, Apr 2023
• Assessment of regulatory T cells (Tregs) and Foxp3 methylation level in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy
  Sabir SF et al. Immunogenetics, April 2023

 
COVID-19 + CML

• The impact of COVID-19 in patients with chronic myeloid leukemia – a nationwide population-based study
  Dahlén T et al. Leukemia, April 2023 (epub ahead of print) – open access publication